165 related articles for article (PubMed ID: 37869066)
1. Complications of transvaginal radiofrequency ablation of fibroids: A 5-year experience.
Santalla-Hernández A; Naveiro-Fuentes M; Benito-Villena R; Villegas-Alcazar J; López-Criado MS; Lara-Serrano A; Parra JF; Alcázar JL; Pelayo-Delgado I
Eur J Obstet Gynecol Reprod Biol X; 2023 Dec; 20():100244. PubMed ID: 37869066
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study.
Turtulici G; Orlandi D; Dedone G; Mauri G; Fasciani A; Sirito R; Silvestri E
Int J Hyperthermia; 2019 Jan; 35(1):97-104. PubMed ID: 30012030
[TBL] [Abstract][Full Text] [Related]
3. Uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.
Fasciani A; Turtulici G; Pedullà A; Sirito R
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():23-28. PubMed ID: 36527825
[TBL] [Abstract][Full Text] [Related]
4. Comparison between radiofrequency ablation combined with mifepristone and radiofrequency ablation for large uterine fibroids.
Hai N; Hou Q; Dong X; Guo R
Int J Hyperthermia; 2021; 38(1):777-780. PubMed ID: 33980123
[TBL] [Abstract][Full Text] [Related]
5. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, Complications, and Factors Predictive of Response to Treatment with Transvaginal Radiofrequency Ablation for Symptomatic Uterine Myomas.
Santalla-Hernández Á; Naveiro-Fuentes M; Benito-Villena R; López-Criado MS; González-Paredes A; Fernández-Parra J
J Minim Invasive Gynecol; 2022 Jun; 29(6):743-752. PubMed ID: 35091094
[TBL] [Abstract][Full Text] [Related]
7. Transcervical radiofrequency ablation of fibroids that are 5 cm or larger in women with abnormal uterine bleeding.
Piriyev E; Schiermeier S; Bends R; Römer T
J Gynecol Obstet Hum Reprod; 2022 Feb; 51(2):102303. PubMed ID: 34973479
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the Sonata System: a retrospective follow-up study.
van der Meulen JF; Cooijmans TH; van Zutven VJ; Leemans JC; Verhoeven CJ; Bongers MY
AJOG Glob Rep; 2022 Nov; 2(4):100087. PubMed ID: 36536842
[TBL] [Abstract][Full Text] [Related]
9. Transcervical intrauterine radiofrequency ablation of fibroids in high-risk patients with bleeding disorder.
Piriyev E; Bends R; Schiermeier S; Romer T
Ginekol Pol; 2022; 93(8):614-619. PubMed ID: 35894488
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas.
Fasciani A; Turtulici G; Siri G; Ferrero S; Sirito R
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32178351
[No Abstract] [Full Text] [Related]
11. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
12. Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.
Christoffel L; Römer T; Schiermeier S
Med Devices (Auckl); 2021; 14():77-84. PubMed ID: 33688276
[TBL] [Abstract][Full Text] [Related]
13. The Research of Feasibility and Efficacy of Radiofrequency Ablation in Treating Uterine Fibroids.
Luo X; Shu SR; Ma XF; Shuai HL
Medicine (Baltimore); 2015 Nov; 94(47):e1956. PubMed ID: 26632689
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis.
Lin L; Ma H; Wang J; Guan H; Yang M; Tong X; Zou Y
J Minim Invasive Gynecol; 2019; 26(3):409-416. PubMed ID: 30253997
[TBL] [Abstract][Full Text] [Related]
15. Transvaginal Radiofrequency Ablation of Myomas: Technique, Outcomes, and Complications.
Rey VE; Labrador R; Falcon M; Garcia-Benitez JL
J Laparoendosc Adv Surg Tech A; 2019 Jan; 29(1):24-28. PubMed ID: 30198831
[TBL] [Abstract][Full Text] [Related]
16. Transvaginal radiofrequency thermal ablation: a day-care approach to symptomatic uterine myomas.
Cho HH; Kim JH; Kim MR
Aust N Z J Obstet Gynaecol; 2008 Jun; 48(3):296-301. PubMed ID: 18532962
[TBL] [Abstract][Full Text] [Related]
17. Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids.
Shifrin G; Engelhardt M; Gee P; Pschadka G
Int J Gynaecol Obstet; 2021 Oct; 155(1):79-85. PubMed ID: 33544889
[TBL] [Abstract][Full Text] [Related]
18. Ultra-structure changes and survivin expression in uterine fibroids after radiofrequency ablation.
Shu SR; Luo X; Song WX; Chen PW
Int J Hyperthermia; 2015; 31(8):896-9. PubMed ID: 26446892
[TBL] [Abstract][Full Text] [Related]
19. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
20. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids.
Brölmann H; Bongers M; Garza-Leal JG; Gupta J; Veersema S; Quartero R; Toub D
Gynecol Surg; 2016; 13():27-35. PubMed ID: 26918001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
